Understanding MASLD, risk factors, diagnosis and treatment
Fatty liver disease occurs when excess fat accumulates inside liver cells. It is now commonly called MASLD — metabolic dysfunction-associated steatotic liver disease. It is frequently associated with obesity, diabetes, high cholesterol, high triglycerides and sedentary lifestyle.
Fatty liver is not always harmless. In some patients, it can progress to liver inflammation, fibrosis, cirrhosis and even liver cancer. Many patients have no symptoms in the early stages, which is why proper risk assessment is important.
Most patients are asymptomatic. Some may have fatigue, heaviness in the right upper abdomen, or abnormal liver enzymes on routine blood tests. Symptoms usually appear late when advanced fibrosis or cirrhosis develops.
Yes, early fatty liver can improve significantly. Weight reduction, regular exercise, control of diabetes, healthy diet and avoidance of unnecessary alcohol or hepatotoxic medicines are central to treatment. Even 7–10% weight loss can improve liver fat and inflammation in many patients.
For specialist evaluation of fatty liver disease and liver fibrosis risk, you can book an online consultation.
Book Online Consultation